In a recent report, Roy, Alexander, and Duthie (1955) reviewed the literature on the characteristics of anaemia in rheumatoid arthritis and described abnormalities of iron metabolism in this disease. It was shown that the anaemia did not present the typical features of iron-deficiency and that there was no evidence of impaired absorption of iron from the gut in the majority of cases. Decreased survival of erythrocytes transfused from healthy donors to patients with active rheumatoid arthritis had been observed, and it was suggested that a reduced lifespan of the patient's own red cells might be a factor in the production of anaemia.
There are few reports on the fate of transfused red cells in rheumatoid arthritis. Brown, Hayward, Powell, and Witts (1944) found that cell survival was normal in one patient with "severe disease". It was not made clear if this implied that evidence of active inflammation was still present. Mollison and Paterson (1949) gave two transfusions to each of two patients suffering from rheumatoid arthritis. Cells used for the first transfusion in each case were incubated in vitro with serum containing Rh-blocking antibody and in both instances survival of the transfused cells was markedly reduced. Both patients were transfused again with cells which had not been exposed to blocking antibody. In one case rapid destruction was again observed, but in the other, cell survival was of normal duration.
Since the start of the present investigation two further reports have appeared. Freireich, Ross, Bayles, Emerson, and Finch (1954) measured the survival of transfused cells in patients with rheumatoid arthritis and found it to be decreased, destruction being most marked in patients with active disease. Bunim (1954) , who used 51Cr. to measure the survival of patient's own red cells, stated that an increased rate of destruction was recorded in patients with active rheumatoid arthritis.
The present study was designed to investigate more thoroughly the possibility that abnormal destruction of red cells might be a factor in the causation of anaemia in rheumatoid arthritis. The first part of the report deals with studies of the survival of cells from healthy donors in patients with active disease and varying degrees of anaemia.
It Twelve of the patients were transfused on more than one occasion, but the data given in Fig. 1 refer only to the first transfusion. The nineteenth patient in the series is omitted from Table I and Fig. 1 as rheumatoid cells were given in the first transfusion.
The initial loss of transfused cells in the rheumatoid recipients was abnormally rapid in all cases. Subsequently the rate of destruction became more linear in character, resembling that seen in the controls. The duration of survival of transfused cells was calculated from the formulae evolved by Brown and others (1944) . The figures for mean survival time correspond to the "average life (1 days)" used by these authors. In six cases of idiopathic hypochromic anaemia investigated by them the average life (1 days) ranged from 38 2 to 53 * 9 with a mean of 44 -8. The mean survival time for each patient is shown in Table I . The average of the means was 17 6 with a standard deviation of 4 88.
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In the second patient to whom ACTH was administered, complete suppression of signs of the disease was not achieved with the dose given. The erythrocyte sedimentation rate did not return to normal although the patient was free from symptoms (Fig. 4) . Disappearance of cells after the first transfusion was very rapid and after the second the rate was not materially altered by the administration of ACTH. Effect of Intravenous Iron on Survival of Cells tch trans-transfused from Healthy Donors.-Three patients adequate in Group II were given 2 g. saccharated oxide of ythrocyte iron intravenously before the second transfusion. efore the The iron was administered to one patient immedi- 
